(Q44181543)

30 November 2017

A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans (English)

1 reference

30 November 2017

1 reference

Kolida S

1

1 reference

30 November 2017

Meyer D

series ordinal

2

1 reference

30 November 2017

Gibson GR

series ordinal

3

1 reference

30 November 2017

language of work or name

1 reference

31 January 2007

1 reference

European Journal of Clinical Nutrition

30 November 2017

1 reference

30 November 2017

61

1 reference

30 November 2017

1189-1195

1 reference

30 November 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ejcn.1602636

30 November 2017

0 references

cites work

Promoting breastfeeding: a view of the current position and a proposed agenda for action in Scotland.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Effects of inulin on faecal bifidobacteria in human subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Presence of inulin and oligofructose in the diets of Americans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

The bifidogenic nature of chicory inulin and its hydrolysis products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides--a human volunteer study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

On the presence of inulin and oligofructose as natural ingredients in the western diet

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Use of probiotics in childhood gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602636

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1602636

1 reference

30 November 2017

1 reference